"Our next guest is Dr. Edward Maggio, CEO of Cengent Therapeutics, headquartered in San Diego, CA. Cengent Therapeutics is a structure-guided drug discovery company utilizing integrated, proprietary computational and experimental technologies to accelerate and optimize drug discovery. Cengent was formed following the synergistic merger of Structural Bioinformatics, Inc. and GeneFormatics, Inc., both leaders in structure-driven drug discovery. Cengent provides the most comprehensive suite of structural services and capabilities for accelerating and optimizing drug discovery from target identification, structure determination, and lead generation to lead optimization and preclinical development. Cengent currently has four preclinical programs in obesity/diabetes, anti-infectives, oncology, and inflammation. The company has raised over $90 million to date from investors."
If the speaker icon doesn't respond then I recommend right-clicking it and selecting "save target as". Save it and try opening that. That's the only way I could get it to run.
By: maxleverage 30 Nov 2003, 12:35 PM EST Msg. 17673 of 17701 Jump to msg. # Maggio says Cengent has/will have a tool that can predict, with over 91% accuracy, whether a breast cancer tumor will reappear within 5 years. Heard that on the interview. eom
News 
Market Data 
Discover 
AI
